Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-11 for Thrombocytopenia in Childhood ALL
NCT02314273Phase 4Completed
- Start
- Sep 2011
- Primary completion
- Apr 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oprelvekin in Thrombocytopenia (2 arms). Primary endpoint: Platelet infusion at 14 days. Started Sep 2011; status: completed.
02
Drugs
oprelvekin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02314273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314273.